NK Cell Activation in Human Hantavirus Infection Explained by Virus-Induced IL-15/IL15Rα Expression

PLoS Pathogens

Volumn 10, Issue 11, 2014, Pages

  Braun, Monika ^a   Björkström, Niklas K ^a   Gupta, Shawon ^b   Sundström, Karin ^b   Ahlm, Clas ^c   Klingström, Jonas ^a,b   Ljunggren, Hans Gustaf ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD107 ANTIGEN; CD155 ANTIGEN; CD38 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA E ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR ALPHA; LYMPHOCYTE ANTIGEN; MESSENGER RNA; NATURAL KILLER CELL RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VIRUS RNA; IL15 PROTEIN, HUMAN; IL15RA PROTEIN, HUMAN; INTERLEUKIN 15 RECEPTOR;

APOPTOSIS; ARTICLE; BIOASSAY; BLOOD SAMPLING; CELL ACTIVATION; CELL CONTACT; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW CYTOMETRY; HANTAVIRUS INFECTION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; GENE EXPRESSION REGULATION; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; IMMUNOLOGY; K562 CELL LINE; LYMPHOCYTE ACTIVATION; PATHOLOGY; PUUMALA VIRUS; VIROLOGY;

HANTAVIRUS;

ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; INTERLEUKIN-15; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; PUUMALA VIRUS; RECEPTORS, INTERLEUKIN-15;

EID: 84912122993     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004521     Document Type: Article

References (62)

1. Vaheri A, Strandin T, Hepojoki J, Sironen T, Henttonen H, et al. (2013) Uncovering the mysteries of hantavirus infections. Nat Rev Microbiol 11: 539–550.
2. Mackow ER, Gavrilovskaya IN, (2009) Hantavirus regulation of endothelial cell functions. Thromb Haemost 102: 1030–1041.
3. Bjorkstrom NK, Lindgren T, Stoltz M, Fauriat C, Braun M, et al. (2011) Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 208: 13–21.
4. Lindgren T, Ahlm C, Mohamed N, Evander M, Ljunggren H-G, et al. (2011) Longitudinal Analysis of the Human T Cell Response during Acute Hantavirus Infection. J Virol 85: 10252–60.
5. Terajima M, Ennis FA, (2011) T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome. Viruses 3: 1059–1073.
6. Van Epps HL, Terajima M, Mustonen J, Arstila TP, Corey EA, et al. (2002) Long-lived memory T lymphocyte responses after hantavirus infection. J Exp Med 196: 579–588.
7. Rasmuson J, Pourazar J, Linderholm M, Sandstrom T, Blomberg A, et al. (2011) Presence of activated airway T lymphocytes in human puumala hantavirus disease. Chest 140: 715–722.
8. Klingstrom J, Hardestam J, Stoltz M, Zuber B, Lundkvist A, et al. (2006) Loss of cell membrane integrity in puumala hantavirus-infected patients correlates with levels of epithelial cell apoptosis and perforin. J Virol 80: 8279–8282.
9. Schonrich G, Rang A, Lutteke N, Raftery MJ, Charbonnel N, et al. (2008) Hantavirus-induced immunity in rodent reservoirs and humans. Immunol Rev 225: 163–189.
10. Klingstrom J, Ahlm C, (2011) Hantavirus protein interactions regulate cellular functions and signaling responses. Expert Rev Anti Infect Ther 9: 33–47.
11. Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, et al. (1995) Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 146: 552–579.
12. Gupta S, Braun M, Tischler ND, Stoltz M, Sundström KB, et al. (2013) Hantavirus-infection Confers Resistance to Cytotoxic Lymphocyte-Mediated Apoptosis. PLoS Pathog 9: e1003272.
13. Jost S, Altfeld M, (2013) Control of Human Viral Infections by Natural Killer Cells. Annu Rev Immunol. 18: 391–398.
14. Lodoen MB, Lanier LL, (2006) Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 18: 391–398.
15. Orange JS, (2006) Human natural killer cell deficiencies. Curr Opin Allergy Clin Immunol 6: 399–409.
16. Lanier LL, (2005) NK cell recognition. Annu Rev Immunol 23: 225–274.
17. Lanier LL, (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9: 495–502.
18. Bryceson YT, Long EO, (2008) Line of attack: NK cell specificity and integration of signals. Curr Opin Immunol 344–352.
19. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, et al. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709–713.
20. Raulet DH, Vance RE, (2006) Self-tolerance of natural killer cells. Nat Rev Immunol 6: 520–531.
21. Anfossi N, Andre P, Guia S, Falk CS, Roetynck S, et al. (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25: 331–342.
22. Dokun AO, Kim S, Smith HR, Kang HS, Chu DT, et al. (2001) Specific and nonspecific NK cell activation during virus infection. Nat Immunol 2: 951–956.
23. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP, (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 17: 189–220.
24. Fehniger TA, Caligiuri MA, (2001) Interleukin 15: biology and relevance to human disease. Blood 97: 14–32.
25. Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, et al. (1995) Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 14: 3654–3663.
26. Anderson DM, Kumaki S, Ahdieh M, Bertles J, Tometsko M, et al. (1995) Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes. J Biol Chem 270: 29862–29869.
27. Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA, (1996) IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity 4: 329–336.
28. Diniz SN, Pendeloski KP, Morgun A, Chepelev I, Gerbase-DeLima M, et al. (2010) Tissue-specific expression of IL-15RA alternative splicing transcripts and its regulation by DNA methylation. Eur Cytokine Netw 21: 308–318.
29. Dubois S, Mariner J, Waldmann TA, Tagaya Y, (2002) IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 17: 537–547.
30. Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, et al. (2009) IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med 206: 25–34.
31. Strowig T, Chijioke O, Carrega P, Arrey F, Meixlsperger S, et al. (2010) Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 116: 4158–4167.
32. Baume DM, Robertson MJ, Levine H, Manley TJ, Schow PW, et al. (1992) Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells. Eur J Immunol 22: 1–6.
33. Azimi N, Shiramizu KM, Tagaya Y, Mariner J, Waldmann TA, (2000) Viral activation of interleukin-15 (IL-15): characterization of a virus-inducible element in the IL-15 promoter region. J Virol 74: 7338–7348.
34. Zdrenghea MT, Telcian AG, Laza-Stanca V, Bellettato CM, Edwards MR, et al. (2012) RSV infection modulates IL-15 production and MICA levels in respiratory epithelial cells. Eur Respir J 39: 712–720.
35. Lalwani P, Raftery MJ, Kobak L, Rang A, Giese T, et al. (2013) Hantaviral mechanisms driving HLA class I antigen presentation require both RIG-I and TRIF. Eur J Immunol 43: 2566–76.
36. Amadei B, Urbani S, Cazaly A, Fisicaro P, Zerbini A, et al. (2010) Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus. Gastroenterology 138: 1536–45.
37. Fauriat C, Long EO, Ljunggren HG, Bryceson YT, (2010) Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115: 2167–2176.
38. Safronetz D, Prescott J, Feldmann F, Haddock E, Rosenke R, et al. (2014) Pathophysiology of hantavirus pulmonary syndrome in rhesus macaques. Proc Natl Acad Sci U S A
39. Azeredo EL, De Oliveira-Pinto LM, Zagne SM, Cerqueira DIS, Nogueira RMR, et al. (2006) NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clin Exp Immunol 345–356.
40. Boyiadzis M, Memon S, Carson J, Allen K, Szczepanski MJ, et al. (2008) Up-regulation of NK cell activating receptors following allogeneic hematopoietic stem cell transplantation under a lymphodepleting reduced intensity regimen is associated with elevated IL-15 levels. Biol Blood Marrow Transplant 14: 290–300.
41. Jost S, Quillay H, Reardon J, Peterson E, Simmons RP, et al. (2011) Changes in cytokine levels and NK cell activation associated with influenza. PLoS One 6: e25060.
42. Oppenheimer-Marks N, Brezinschek RI, Mohamadzadeh M, Vita R, Lipsky PE, (1998) Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo. J Clin Invest 101: 1261–1272.
43. Barreira da Silva R, Münz C, (2011) Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals. Cell Mol Life Sci 68: 3505–18.
44. Brilot F, Strowig T, Roberts SM, Arrey F, Munz C, (2007) NK cell survival mediated through the regulatory synapse with human DCs requires IL-15Ralpha. J Clin Invest 117: 3316–3329.
45. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, et al. (2002) Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195: 343–351.
46. Morandi B, Mortara L, Chiossone L, Accolla RS, Mingari MC, et al. (2012) Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. PLoS One 7: e39170.
47. Russier M, Reynard S, Tordo N, Baize S, (2012) NK cells are strongly activated by Lassa and Mopeia virus-infected human macrophages in vitro but do not mediate virus suppression. Eur J Immunol 42: 1822–1832.
48. Brodin P, Kärre K, Höglund P, (2009) NK cell education: not an on-off switch but a tunable rheostat. Trends Immunol 30: 143–149.
49. Della Chiesa M, Vitale M, Carlomagno S, Ferlazzo G, Moretta L, et al. (2003) The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur J Immunol 33: 1657–1666.
50. Abdul-Careem MF, Mian MF, Yue G, Gillgrass A, Chenoweth MJ, et al. (2012) Critical role of natural killer cells in lung immunopathology during influenza infection in mice. J Infect Dis 206: 167–177.
51. Pembroke T, Christian A, Jones E, Hills RK, Wang EC, et al. (2014) The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon alpha treatment. Gut 63: 515–524.
52. Courouble P, Vanpee D, Delgrange E, Donckier J, Pochet JM, et al. (2001) Hantavirus infections: clinical presentation in the emergency room. Eur J Emerg Med 8: 17–20.
53. Outinen TK, Kuparinen T, Jylhava J, Leppanen S, Mustonen J, et al. (2012) Plasma cell-free DNA levels are elevated in acute Puumala hantavirus infection. PLoS One 7: e31455.
54. Vieillard V, Strominger JL, Debre P, (2005) NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc Natl Acad Sci U S A 102: 10981–10986.
55. Jonsson CB, Hooper J, Mertz G, (2008) Treatment of hantavirus pulmonary syndrome. Antiviral Res 78: 162–169.
56. McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY, (1997) Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis. Nat Med 3: 189–195.
57. Blanco-Jerez C, Plaza JF, Masjuan J, Orensanz LM, Alvarez-Cermeno JC, (2002) Increased levels of IL-15 mRNA in relapsing–remitting multiple sclerosis attacks. J Neuroimmunol 128: 90–94.
58. Zambello R, Facco M, Trentin L, Sancetta R, Tassinari C, et al. (1997) Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood 89: 201–211.
59. Waldmann TA, Conlon KC, Stewart DM, Worthy TA, Janik JE, et al. (2013) Phase 1 trial of IL-15 trans presentation blockade using humanized Mikbeta1 mAb in patients with T-cell large granular lymphocytic leukemia. Blood 121: 476–484.
60. Evander M, Eriksson I, Pettersson L, Juto P, Ahlm C, et al. (2007) Puumala hantavirus viremia diagnosed by real-time reverse transcriptase PCR using samples from patients with hemorrhagic fever and renal syndrome. J Clin Microbiol 45: 2491–2497.
61. Stoltz M, Klingstrom J, (2010) Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection. J Virol 84: 9140–9148.
62. Hardestam J, Klingstrom J, Mattsson K, Lundkvist A, (2005) HFRS causing hantaviruses do not induce apoptosis in confluent Vero E6 and A-549 cells. J Med Virol 76: 234–240.